KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to $107.1 million.

  • Pacira BioSciences' Total Current Liabilities fell 6505.3% to $107.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.1 million, marking a year-over-year decrease of 6505.3%. This contributed to the annual value of $309.9 million for FY2024, which is 21824.86% up from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Total Current Liabilities is $107.1 million, which was down 6505.3% from $313.2 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Total Current Liabilities registered a high of $521.1 million during Q4 2021, and its lowest value of $92.7 million during Q2 2024.
  • For the 5-year period, Pacira BioSciences' Total Current Liabilities averaged around $203.2 million, with its median value being $147.8 million (2022).
  • Per our database at Business Quant, Pacira BioSciences' Total Current Liabilities tumbled by 7164.29% in 2022 and then surged by 23786.17% in 2025.
  • Pacira BioSciences' Total Current Liabilities (Quarter) stood at $521.1 million in 2021, then crashed by 71.64% to $147.8 million in 2022, then plummeted by 34.1% to $97.4 million in 2023, then surged by 218.25% to $309.9 million in 2024, then plummeted by 65.45% to $107.1 million in 2025.
  • Its Total Current Liabilities stands at $107.1 million for Q3 2025, versus $313.2 million for Q2 2025 and $314.7 million for Q1 2025.